(Q38529003)

3 September 2017

1 reference

title

Heart failure with preserved ejection fraction: uncertainties and dilemmas (English)

1 reference

Heart failure with preserved ejection fraction

3 September 2017

0 references

1 reference

1 reference

Claudio Rapezzi

6

0 references

Luigi Tavazzi

7

object named as

Luigi Tavazzi

1 reference

3 September 2017

5

Burkert Pieske

1 reference

3 September 2017

Roberto Ferrari

1

1 reference

3 September 2017

Michael Böhm

2

1 reference

3 September 2017

John G F Cleland

3

1 reference

3 September 2017

Walter J S Paulus

4

1 reference

3 September 2017

16 June 2015

1 reference

European Journal of Heart Failure

3 September 2017

1 reference

3 September 2017

17

1 reference

3 September 2017

7

1 reference

3 September 2017

665-671

1 reference

HFNEF, HFpEF, HF-PEF, or DHF: what is in an acronym?

3 September 2017

1 reference

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

21 January 2018

1 reference

B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.

21 January 2018

1 reference

Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial

21 January 2018

1 reference

Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction

21 January 2018

1 reference

High prevalence of undetected heart failure in long-term care residents: findings from the Heart Failure in Care Homes (HFinCH) study

21 January 2018

1 reference

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

Right heart dysfunction in heart failure with preserved ejection fraction

21 January 2018

1 reference

Right ventricular function in heart failure with preserved ejection fraction: a community-based study

21 January 2018

1 reference

Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

21 January 2018

1 reference

What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?

21 January 2018

1 reference

Outcome of heart failure with preserved ejection fraction in a population-based study

21 January 2018

1 reference

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

21 January 2018

1 reference

Mortality in heart failure with preserved ejection fraction: an unacceptably high rate

21 January 2018

1 reference

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

21 January 2018

1 reference

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

21 January 2018

1 reference

Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction

21 January 2018

1 reference

Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.

21 January 2018

1 reference

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

21 January 2018

1 reference

In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry

21 January 2018

1 reference

Heart failure with preserved ejection fraction: a clinical dilemma

21 January 2018

1 reference

How do patients with heart failure with preserved ejection fraction die?

21 January 2018

1 reference

The pathophysiology of heart failure with preserved ejection fraction.

21 January 2018

1 reference

Developing therapies for heart failure with preserved ejection fraction: current state and future directions

21 January 2018

1 reference

Clinical trials in patients with heart failure and preserved left ventricular ejection fraction

21 January 2018

1 reference

Systolic and diastolic heart failure: different phenotypes of the same disease?

21 January 2018

1 reference

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes

21 January 2018

1 reference

Natural history of left ventricular ejection fraction in patients with heart failure

21 January 2018

1 reference

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

21 January 2018

1 reference

Central obesity: association with left ventricular dysfunction and mortality in the community

21 January 2018

1 reference

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin

21 January 2018

1 reference

Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.

21 January 2018

1 reference

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.

21 January 2018

1 reference

Longitudinal changes in left ventricular stiffness: a community-based study

21 January 2018

1 reference

Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload

21 January 2018

1 reference

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

21 January 2018

1 reference

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

Irbesartan in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.

21 January 2018

1 reference

Spironolactone for heart failure with preserved ejection fraction

21 January 2018

1 reference

Lessons from the TOPCAT Trial

21 January 2018

1 reference

Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

21 January 2018

1 reference

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

21 January 2018

1 reference

Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?

21 January 2018

1 reference

Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis

21 January 2018

1 reference

Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications

21 January 2018

1 reference

The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure

21 January 2018

1 reference

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

21 January 2018

1 reference

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

21 January 2018

1 reference

Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report

21 January 2018

1 reference

Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction

21 January 2018

1 reference

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

21 January 2018

1 reference

Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES).

21 January 2018

1 reference

Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes

21 January 2018

1 reference

Increased late sodium current in myocytes from a canine heart failure model and from failing human heart.

21 January 2018

1 reference

RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study

21 January 2018

1 reference

Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).

21 January 2018

1 reference

Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise

21 January 2018

1 reference

Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.

21 January 2018

1 reference

Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction

21 January 2018

1 reference

Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction

21 January 2018

1 reference

Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction

21 January 2018

1 reference

Diastolic Stiffness of the Failing Diabetic Heart

21 January 2018

1 reference

Heart Rate Predicts Mortality in Patients With Heart Failure and Preserved Systolic Function

21 January 2018

1 reference

The pathogenesis of acute pulmonary edema associated with hypertension

21 January 2018

1 reference

7 January 2021

Cardiomyocyte Stiffness in Diastolic Heart Failure

1 reference

7 January 2021

Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

1 reference

7 January 2021

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

7 January 2021

Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol

1 reference

7 January 2021

Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure

1 reference

7 January 2021

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey

1 reference

7 January 2021

Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/EJHF.304

1 reference

3 September 2017

1 reference